Skip to main content

Table 3 The variation of the ET-1 concentration among patients according risk factors

From: Pathological interactions between the endothelin-1 and the angiotensin- converting enzyme among Tunisian coronary patients

Populations and risk factors ET-1 (nM/L) p
Gender Men (n = 121) 17.4 ± 4.6 <0.00001
Women (n = 36) 7.8 ± 2.3
Hypertension Yes (n = 138) 16.4 ± 3.3 <0.00001
No (n = 19) 6.6 ± 1.9
Diabetes Yes (n = 101) 15 ± 5.1 NS
No (n = 56) 15.6 ± 3.8
Tobacco Yes (n = 98) 11.6 ± 3 <0.00001
No (n = 59) 21.2 ± 6.1
Personal cardiovascular antecedents Yes (n = 104) 15.3 ± 4.4 NS
No (n = 53) 15 ± 2.8
Obesity Yes (n = 82) 12.2 ± 5.3 <0.001
No (n = 75) 18.2 ± 4
Dyslipidemia Yes (n = 63) 11.8 ± 1.6 <0.00001
No (n = 94) 17 .5 ± 4.6
Alcohol Yes (n = 52) 16 ± 4.1 NS
No (n = 105) 14.8 ± 3.8
Sedentarity Yes (n = 67) 15.7 ± 3.7 NS
No (n = 90) 14.9 ± 2.4
  1. NS not significant (p > 0.05)